The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients.
Schendel
Dolores J
DJ
Institute of Molecular Immunology, GSF National Research Center for Environment and Health, Munich, Germany. schendel@gsf.de
Falk
C S
CS
Frankenberger
B
B
Noessner
E
E
Schleypen
J
J
Pohla
H
H
D002292:Carcinoma, Renal Cell / Q000276:immunology*; D045744:Cell Line, Tumor; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D007680:Kidney Neoplasms / Q000276:immunology*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology*; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D008285:Major Histocompatibility Complex / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D019139:Tumor Escape / Q000276:immunology
D011948:Receptors, Antigen, T-Cell